PT - JOURNAL ARTICLE AU - McDonald, Daniel J. AU - Bien, Jacob AU - Green, Alden AU - Hu, Addison J. AU - DeFries, Nat AU - Hyun, Sangwon AU - Oliveira, Natalia L. AU - Sharpnack, James AU - Tang, Jingjing AU - Tibshirani, Robert AU - Ventura, Valérie AU - Wasserman, Larry AU - Tibshirani, Ryan J. TI - Can Auxiliary Indicators Improve COVID-19 Forecasting and Hotspot Prediction? AID - 10.1101/2021.06.22.21259346 DP - 2021 Jan 01 TA - medRxiv PG - 2021.06.22.21259346 4099 - http://medrxiv.org/content/early/2021/11/09/2021.06.22.21259346.short 4100 - http://medrxiv.org/content/early/2021/11/09/2021.06.22.21259346.full AB - Short-term forecasts of traditional streams from public health reporting (such as cases, hospitalizations, and deaths) are a key input to public health decision-making during a pandemic. Since early 2020, our research group has worked with data partners to collect, curate, and make publicly available numerous real-time COVID-19 indicators, providing multiple views of pandemic activity in the U.S. This paper studies the utility of five such indicators—derived from de-identified medical insurance claims, self-reported symptoms from online surveys, and COVID-related Google search activity—from a forecasting perspective. For each indicator, we ask whether its inclusion in an autoregressive (AR) model leads to improved predictive accuracy relative to the same model excluding it. Such an AR model, without external features, is already competitive with many top COVID-19 forecasting models in use today. Our analysis reveals that (a) inclusion of each of these five indicators improves on the overall predictive accuracy of the AR model; (b) predictive gains are in general most pronounced during times in which COVID cases are trending in “flat” or “down” directions; (c) one indicator, based on Google searches, seems to be particularly helpful during “up” trends.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis material is based on work supported by gifts from Facebook, Google.org, the McCune Foundation, and Optum; Centers for Disease Control and Prevention (CDC) grant U01IP001121; the Canadian Statistical Sciences Institute; National Sciences and Engineering Research Council of Canada (NSERC) grant RGPIN-2021-02618; and National Science Foundation Graduate Research Fellowship Program (NSF GRFP) award DGE1745016.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:no IRB approval is required.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is publicly available from the linked URL to the COVIDcast Epidata API. https://cmu-delphi.github.io/delphi-epidata/api/covidcast.html